Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Charmacy Pharmaceutical CoHKSE:02289 76 Days Inventory is 67.22 as of Dec. 2025, which is 24% above its 10-year median of 54.37. GuruFocus rates HKSE:02289 with a GF Score™ of 76/100 and a GF Value™ of HK$8.38 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 117 Medical Distribution companies, Charmacy Pharmaceutical Co ranks worse than 58.97% on this metric.
The historical rank and industry rank for Charmacy Pharmaceutical Co's Days Inventory or its related term are showing as below:
HKSE:02289'
s Days Inventory Range Over the Past 10 Years
Min: 35.89 Med: 54.37 Max: 64.84
Current: 64.84
During the past 12 years, Charmacy Pharmaceutical Co's highest Days Inventory was 64.84. The lowest was 35.89. And the median was 54.37.
HKSE:02289's Days Inventory is ranked worse than 58.97% of 117
companies
in the Medical Distribution industry
Industry Median: 55.31
vs HKSE:02289: 64.84
Inventory Turnover measures how fast the company turns over its inventory within a year.
Charmacy Pharmaceutical Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 2.71.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Charmacy Pharmaceutical Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.34.
Charmacy Pharmaceutical Co (HKSE:02289) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Charmacy Pharmaceutical Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Charmacy Pharmaceutical Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Charmacy Pharmaceutical Co Days Inventory Related Terms
Charmacy Pharmaceutical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02289 vs MCK, COR, CAH: Days Inventory Comparison
For the Medical Distribution subindustry, Charmacy Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Charmacy Pharmaceutical Co Days Inventory vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Charmacy Pharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Charmacy Pharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charmacy Pharmaceutical Co (HKSE:02289) has a Days Inventory of 67.22 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Charmacy Pharmaceutical Co and its competitors. This is 24% above median its historical median of 54.37. Over the past decade, Charmacy Pharmaceutical Co's Days Inventory has ranged from 35.89 to 64.84. According to the industry distribution chart, Charmacy Pharmaceutical Co ranks #69 out of 117 companies in the Medical Distribution industry, placing it in the top 59%.
Is Charmacy Pharmaceutical Co's Days Inventory too high?
Charmacy Pharmaceutical Co's current Days Inventory of 67.22 is 24% above median its 10-year median of 54.37. Over the past 10 years, this metric has ranged from a low of 35.89 to a high of 64.84. The Medical Distribution industry median Days Inventory is 55.31. Charmacy Pharmaceutical Co's value of 67.22 is 21.5% above this industry median. Based on the distribution chart, Charmacy Pharmaceutical Co ranks #69 out of 117 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Charmacy Pharmaceutical Co has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Charmacy Pharmaceutical Co's Days Inventory compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Charmacy Pharmaceutical Co ranks #69 out of 117 companies for Days Inventory. This places Charmacy Pharmaceutical Co in the lower half of its industry. The industry median Days Inventory is 55.31. Charmacy Pharmaceutical Co's value of 67.22 is 21.5% above this benchmark. Historically, Charmacy Pharmaceutical Co's own Days Inventory has ranged from 35.89 to 64.84 over the past decade. While the company's 10-year median is 54.37 vs. the industry median of 55.31, Charmacy Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Distribution company?
The median Days Inventory among Medical Distribution companies is 55.31, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Charmacy Pharmaceutical Co's current Days Inventory of 67.22 is 21.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Charmacy Pharmaceutical Co and its competitors. For the Medical Distribution industry, the median Days Inventory is 55.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Charmacy Pharmaceutical Co's current Days Inventory is 67.22, which is 24% above median its own 10-year median of 54.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charmacy Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Charmacy Pharmaceutical Co (HKSE:02289) is currently considered Possible Value Trap. The stock's GF Value™ is HK$8.38, compared to a current price of HK$5.50 — trading 34.4% below its estimated fair value. The current Days Inventory is 67.22, which is 24% above median its 10-year median of 54.37 and 21.5% above the Medical Distribution industry median of 55.31. Charmacy Pharmaceutical Co's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Charmacy Pharmaceutical Co (HKSE:02289), the current Days Inventory is 67.22 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Charmacy Pharmaceutical Co (HKSE:02289) Overvalued in 2026?
Based on GuruFocus' analysis, Charmacy Pharmaceutical Co stock appears to be undervalued.
The current stock price of HK$5.50 is trading 34.4% below its estimated GF Value™ of HK$8.38.
GuruFocus considers Charmacy Pharmaceutical Co to be Possible Value Trap.
Key valuation signals for HKSE:02289:
Days Inventory: 67.22 (24% above median its 10-year median of 54.37)
GF Value™: HK$8.38 vs. price of HK$5.50 (34.4% below fair value)
Industry Position: 21.5% above the Medical Distribution median (#69 of 117)
No single metric tells the full story. See the HKSE:02289 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Charmacy Pharmaceutical Co Ltd operates within the pharmaceutical distribution industry, with a primary focus on the distribution of pharmaceutical products. The principal business activities encompass the wholesale of pharmaceuticals and related services, along with road transportation and cargo warehousing. The company's distribution network covers Southern China and surrounding areas including Fujian province. All the group's operations are located in China.
76GF Score
Get the complete analysis for HKSE:02289
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02289 has been successfully added to your 
